Real-time enrollment status for this kras mutant cancer clinical trial
Current Status
Active, Not Recruiting
Checked: June 1, 2026 at 9:13 PM UTC
| NCT Number | NCT05638295 |
| Recruiting Status | Active, Not Recruiting |
| Condition | KRAS Mutant Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 105 participants |
| Active Locations | 176 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | May 13, 2026 (2 weeks ago) |
As of June 1, 2026: Clinical trial NCT05638295 is currently active_not_recruiting participants. This clinical trial study for kras mutant cancer is not currently accepting new participants at 176 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05638295 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 176 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05638295 was last updated 2 weeks ago (May 13, 2026). HelloStudys verifies this status automatically.